Subtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED score

Background: Risk of substantial haemorrhage represents a critically important limitation to effective anti-thrombotic treatment in patients with atrial fibrillation (AF). While it is known that this risk is increased in anticoagulated patients either in the presence of anti-aggregatory drugs or conc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cardiovasc Dis
Autors principals: Procter, Nathan EK, Ball, Jocasta, Heresztyn, Tamila, Nooney, Vivek B, Liu, Saifei, Chong, Cher-Rin, Ngo, Doan TM, Isenberg, Jeffrey S, Chirkov, Yuliy Y, Stewart, Simon, Horowitz, John D
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4539096/
https://ncbi.nlm.nih.gov/pubmed/26309773
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars